Author:
Winer Rachel L.,Lin John,Anderson Melissa L.,Tiro Jasmin A.,Meenan Richard T.,Hansen Kristina,Gao Hongyuan,Sparks Angela,Greene Dina N.,Kilgore-Martin Sony,Green Beverly B.,Buist Diana S.M.
Funder
National Cancer Institute
National Institutes of Health
Subject
Pharmacology (medical),General Medicine
Reference42 articles.
1. Assessment of US preventive services task force guideline-concordant cervical Cancer screening rates and reasons for Underscreening by age, race and ethnicity, sexual orientation, rurality, and insurance, 2005 to 2019;Suk;JAMA Netw. Open,2022
2. Impact of COVID-19 on cervical cancer screening: challenges and opportunities to improving resilience and reduce disparities;Wentzensen;Prev. Med.,2021
3. Cancer statistics, 2020, CA;Siegel;Cancer J. Clin.,2020
4. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process;Leyden;J. Natl. Cancer Inst.,2005
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献